ГОСТ 32641-2014
Библиография
[I]Руководящий документ OECD Test N
p
407 «Repeated Dose 28-Day Oral Toxicity Study in
Rodents»
[2JOECD (Paris. 1992). Chairman’s Report of the Meeting of the ad hoc Working Group of
Experts on Systemic Short-term and (Delayed) Neurotoxicity
[3]IPCS (1986). Principles and Methods for the Assessment of Neurotoxicity Associated with
Exposure to Chemicals. Environmental Health Criteria Document No. 60
[4]Tupper, D.E., Wallace. R.B. (1980). Utility of the Neurologic Examination in Rats. Acta
Neurobiol. Exp., 40. 999-1003
[5]Gad. S.C. (1982). A Neuromuscular Screen for Use in Industrial Toxicology. J. Toxicol
Environ. Health, 9, 691-704
[6]Moser, V.C., McDaniel, K.M.. Phillips. P.M. (1991). Rat Strain and Stock Comparisons Using a
Functional Observational Battery: Baseline Values and Effects of Amitraz. Toxicol. Appl. Pharmacol.. 108.
267-283
[7]Meyer O.A.. Tilson H.A.. Byrd W.C.. Riley M.T. (1979). A Method for the Routine Assessment
of Fore- and Hindlimb Grip Strength of Rats and Mice. Neurobehav. Toxicol.. 1, 233-236
[8]Crofton K.M., Howard J.L., Moser V.C.. Gill M.W.. Reiter L.W., Tilson H.A., MacPhail R.C.
(1991). Intorlaboratory Comparison of Motor Activity Experiments: Implication for Neurotoxicological
Assessments. Neurotoxicol. Teratol. 13. 599-609
[9]OECD (1998). Report of the First Meeting of the OECD Endocrine Disrupter Testing and
Assessment (EDTA) Task Force, 10th-11th March 1998. ENV/MC/CHEM/RA(98)5
[10]OECD. (2006). Report of the Validation of the Updated Test Guideline 407: Repeat Dose 28-
day Oral Toxicity Study in Laboratory Rats. Series on Testing and Assessment No 59.
ENV/JM/MONO(2006)26
[II]OECD. (2002). Detailed Review Paper on the Appraisal of Test Methods for Sex Hormone
Disrupting Chemicals. Series on Testing and Assessment No 21. ENV/JMyMONO(2002}8
[12]OECD (2002).Conceptual Framework for Testing and Assessment of Endocrine Disrupting
Chemicals
[13]OECD (2006). Final Summary report of the meeting of the Validation Management Group for
mammalian testing. ENV/JM/TG/EDTA/M(2006)2
[14]OECD (2006). Draft Summary record of the meeting of the Task Force on Endocrine
Disrupters Testing and Assessment. ENV/JM/TG/EDTA/M(2006)3
[15]OECD (2000) Guidance document on the recognition, assessment and use of clinical signs as
humane endpoints for experimental animals used in safety evaluation. Series on Testing and Assessment No
19. ENV/JMyMONO{2000)7
[16]P. Haley. R. Perry, D. Ennulat, S. Frame, C. Johnson, J.-M. Lapointe. A. Nyska. P.W. Snyder.
D. Walker, and G. Walter (2005). STP Position Paper: Best Practice Guideline for the Routine Pathology
Evaluation of the Immune System. Toxicol Pathol 2005 33: 404-407
[17]Hess RA. Moore BJ. (1993) Histological Methods for the Evaluation of the Testis. In: Methods
in Reproductive Toxicology, Chapin RE and Heindel JJ (eds). Academic Press: San Diego. CA. pp. 52-85
[18]Latendresse JR. Warbrittion AR, Jonassen H. Creasy DM.(2002) Fixation of testes and eyes
using a modified Davidson’s fluid: comparison with Bouin’s fluid and conventional Davidson’s fluid. Toxicol.
Pathol. 30. 524-533
[19]OECD. (2007). OECD Guideline for Testing of Chemicals №440: Uterotrophic Bioassay in
Rodents: A short-term screening test for oestrogenic properties
[20]OECD. (2008). Guidance Document on histopathology. Endocrine disruption: Guidelines for
histological evaluation (draft). Series on Testing and Assessment
10